NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Prabhudas Lilladher Downgrades AAVAS Financiers to ACCUMULATE

AAVAS Financiers, a leading financial services company, has reported a growth in its 4Q disbursements and Assets Under Management (AUM). According to the company's latest research report by Prabhudas Lilladher, the 4Q disbursements grew by 16% year-over-year (YoY), while AUM saw a growth of 15% YoY. However, the report suggests that the company's growth aspirations of 20%+ may be conservative, given the high competitive intensity in the market.

AAVAS Financiers AUM Growth Projections

YearProjected AUM Growth
FY2718%
FY28E19%

The report indicates that the company's spreads are expected to moderate in FY27 and FY28E, as the book reprices with a reduction in the Prime Lending Rate (PLR) and an increase in the cost of borrowing due to hardening of bond yields. On the other hand, the company is expected to see an improvement in its operational expenses (opex) as productivity benefits flow through, and it does not anticipate any further significant investments in technology.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Based on these factors, Prabhudas Lilladher has tweaked its FY27 and FY28E estimates, factoring in a pick-up in growth and improved opex. The report also adjusts the multiple to 1.9x (earlier 1.8x) with a target price (TP) of Rs 1,585. However, the research firm has downgraded the stock to ACCUMULATE, considering that it has run up by 29% in the past month.

Investor Takeaway

Investors should consider AAVAS Financiers with a price target of Rs 1585.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.